Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
6 results loaded, newest first. End of these results.
For best results when printing this announcement, please click on link below: MaxLinear Accelerates AI-Powered Broadband with Topaz™ and Intelligent Network Innovations at Network X 2026 Live demonstrations showcase AI-ready edge gateways, embedded AI assistants, resilient converged connectivity, and software-defined a
Cell Impact AB announced the acceleration of a previously communicated order.
Cell Impact AB (publ) announced an acceleration of a previously communicated order from a U.S. customer, valued at SEK 5.3 million. The company stated this would strengthen its cash flow and positively affect its liquidity.
Cell Impact accelerated deliveries for a previously announced SEK 5.3 million order from a US customer. Most of the volume will be manufactured and delivered over the next two quarters, with final delivery expected in April 2027. Earlier deliveries are expected to strengthen cash flow and liquidity.
Recursion Pharmaceuticals (NASDAQ: RXRX ) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Recursion Pharma
Oracle reported record first-quarter revenue of $19.3 billion, up 30% year over year, with cloud infrastructure revenue up 121% to $7.4 billion. The company also completed a $20 billion equity issuance and guided Q2 revenue growth of 30% to 34%.